{"id":"https://openalex.org/W2739726441","doi":"https://doi.org/10.1158/1538-7445.am2017-3597","title":"Abstract 3597: Experiences and lessons from innovative dose escalation designs in early-phase oncology","display_name":"Abstract 3597: Experiences and lessons from innovative dose escalation designs in early-phase oncology","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2739726441","doi":"https://doi.org/10.1158/1538-7445.am2017-3597","mag":"2739726441"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-3597","doi":"https://doi.org/10.1158/1538-7445.am2017-3597","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-3597","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042596690","display_name":"Jiawen Zhu","orcid":"https://orcid.org/0000-0003-1634-1814","observed_orcids":["https://orcid.org/0000-0003-1634-1814"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiawen Zhu","raw_affiliation_strings":["1F. Hoffmann-La Roche Ltd, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1F. Hoffmann-La Roche Ltd, New York, NY;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040423968","display_name":"Ulrich Beyer","orcid":"https://orcid.org/0000-0001-5601-2201","observed_orcids":["https://orcid.org/0000-0001-5601-2201"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ulrich Beyer","raw_affiliation_strings":["2F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008874536","display_name":"Somnath Sarkar","orcid":"https://orcid.org/0000-0002-8158-3847","observed_orcids":["https://orcid.org/0000-0002-8158-3847"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Somnath Sarkar","raw_affiliation_strings":["1F. Hoffmann-La Roche Ltd, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1F. Hoffmann-La Roche Ltd, New York, NY;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074661473","display_name":"GWEN L. NICHOLS","orcid":"https://orcid.org/0000-0002-3714-4927","observed_orcids":["https://orcid.org/0000-0002-3714-4927"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gwen Nichols","raw_affiliation_strings":["1F. Hoffmann-La Roche Ltd, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1F. Hoffmann-La Roche Ltd, New York, NY;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062616992","display_name":"William J. Pao","orcid":"https://orcid.org/0000-0002-9888-0733","observed_orcids":["https://orcid.org/0000-0002-9888-0733"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"William Pao","raw_affiliation_strings":["2F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033267761","display_name":"Daniel Saban\u00e9s Bov\u00e9","orcid":"https://orcid.org/0000-0002-0176-9239","observed_orcids":["https://orcid.org/0000-0002-0176-9239"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Daniel Saban\u00e9s Bov\u00e9","raw_affiliation_strings":["2F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"3597","last_page":"3597"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11798","display_name":"Optimal Experimental Design Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1803","display_name":"Management Science and Operations Research"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8330000042915344},{"id":"https://openalex.org/keywords/bayesian-adaptive-design","display_name":"Bayesian adaptive design","score":0.9179999828338623},{"id":"https://openalex.org/keywords/early-phase-oncology-trials","display_name":"early-phase oncology trials","score":0.7950000166893005},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8889999985694885},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9459999799728394},{"id":"https://openalex.org/keywords/3-3-design","display_name":"3+3 design","score":0.8059999942779541},{"id":"https://openalex.org/keywords/trial-simulation","display_name":"trial simulation","score":0.9150000214576721},{"id":"https://openalex.org/keywords/multidisciplinary-collaboration","display_name":"multidisciplinary collaboration","score":0.8190000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6160792708396912},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5807512402534485},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.5076836347579956},{"id":"https://openalex.org/C2780598303","wikidata":"https://www.wikidata.org/wiki/Q65921492","display_name":"Flexibility (engineering)","level":2,"score":0.5041202306747437},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.49695923924446106},{"id":"https://openalex.org/C2777334693","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Maximum tolerated dose","level":3,"score":0.486930251121521},{"id":"https://openalex.org/C188198153","wikidata":"https://www.wikidata.org/wiki/Q1613840","display_name":"Limiting","level":2,"score":0.48566973209381104},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48212313652038574},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3906095623970032},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.22677111625671387},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.13216915726661682},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-3597","doi":"https://doi.org/10.1158/1538-7445.am2017-3597","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-3597","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W291055518","https://openalex.org/W2087645996","https://openalex.org/W2043520919","https://openalex.org/W3162096503","https://openalex.org/W2006990152","https://openalex.org/W7067475011","https://openalex.org/W2953848694","https://openalex.org/W1538000603","https://openalex.org/W2953168091","https://openalex.org/W6927461606"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Since":[2],"2010,":[3],"Roche-sponsored":[4,173],"early":[5,103,313],"development":[6,314],"trials":[7,179],"in":[8,102,123,172,180,195,247,274,282,415],"oncology":[9,104,174,417],"have":[10],"successfully":[11],"implemented":[12],"innovative":[13,411],"dose":[14,55,213,412],"escalation":[15,157,413],"(D/E)":[16],"strategies":[17,121],"including":[18,350],"modified":[19],"continual":[20],"reassessment":[21],"methods":[22,35,118],"(CRM)":[23],"and":[24,46,65,69,90,97,119,138,145,156,209,324,359,367,373,382,387,408],"other":[25,223],"Bayesian":[26],"adaptive":[27],"designs.":[28,125],"Compared":[29,177],"to":[30,39,47,67,178,217,292,311,328,343,361],"standard":[31],"3+3":[32,182],"designs,":[33,349],"these":[34],"allow":[36],"for":[37,341,425],"flexibility":[38,194],"address":[40,329],"a":[41,51,110,248,264,271,330],"variety":[42,331],"of":[43,100,114,140,200,205,211,240,305,332,347,353,369,421],"clinical":[44,105,120,256,333],"questions":[45],"estimate":[48],"more":[49],"accurately":[50],"molecule\u2019s":[52],"maximum":[53],"tolerated":[54],"(MTD).":[56],"However,":[57],"CRM":[58,101,124,170,191,231,261,306,320,348,370],"designs":[59,171,183,192,232,307,321,371,414],"are":[60,70,165,184,322],"sometimes":[61],"considered":[62,309],"as":[63],"complex":[64],"difficult":[66],"implement":[68],"not":[71,244],"easily":[72],"understood":[73],"by":[74],"clinicians":[75,144],"(Le":[76],"Tourneau":[77],"et":[78,82,162],"al.,":[79,163],"2009,":[80],"Iasonos":[81],"al.":[83],"2014).":[84],"Here,":[85],"we":[86,128,186,225],"share":[87],"our":[88,318],"experiences":[89],"learnings":[91],"from":[92,410],"the":[93,115,133,166,206,222,238,260,275,283,345,351,365,380,388,422],"initial":[94],"exploration,":[95],"introduction,":[96],"wide-spread":[98],"implementation":[99,368],"trials.":[106,176,315],"Methods:":[107],"We":[108],"conducted":[109],"thorough":[111],"internal":[112,134],"review":[113],"current":[116],"statistical":[117],"used":[122,169],"In":[126,277],"addition,":[127],"systematically":[129],"collected":[130],"feedback":[131],"on":[132,317],"experience":[135],"through":[136,296],"surveys":[137],"interviews":[139],"participating":[141],"biostatisticians,":[142],"pharmacologists,":[143],"operations":[146],"managers.":[147],"Results:":[148],"CRMs":[149],"using":[150,298],"two":[151],"parameter":[152],"logistic":[153],"regression":[154],"models":[155],"with":[158,190],"overdose":[159],"control":[160],"(Neuenschwander":[161],"2008)":[164],"most":[167],"commonly":[168],"D/E":[175,389],"which":[181],"used,":[185],"experienced":[187],"significant":[188],"advantages":[189],"including:":[193],"cohort":[196,249],"sizes;":[197],"formal":[198],"integration":[199],"relevant":[201],"prior":[202,289,362],"pre-clinical/clinical":[203],"knowledge":[204],"dose-toxicity":[207,284,300],"relationship;":[208],"contribution":[210],"all":[212],"limiting":[214],"toxicities":[215],"(DLTs)":[216],"an":[218,241],"MTD":[219],"determination.":[220],"On":[221],"hand,":[224],"learned":[226],"about":[227],"some":[228],"limitations.":[229],"The":[230],"modeled":[233],"binary":[234],"DLT":[235,252],"events":[236],"where":[237,250],"grade":[239],"event":[242],"was":[243,270,286,308],"considered.":[245],"Thus,":[246],"severe":[251],"event(s)":[253],"were":[254,339],"observed,":[255],"judgment":[257],"typically":[258],"superseded":[259],"recommendation":[262,390],"towards":[263],"lower":[265],"dose;":[266],"this":[267],"decision":[268],"rule":[269],"priori":[272],"defined":[273],"protocol.":[276],"certain":[278],"situations,":[279],"inconsistent":[280],"prior-information":[281],"relationship":[285],"observed.":[287],"Therefore,":[288],"assumptions":[290],"had":[291],"be":[293,326],"carefully":[294],"assessed":[295],"simulations":[297],"multiple":[299],"scenarios.":[301],"Conclusions:":[302],"Overall,":[303],"utilization":[304],"beneficial":[310],"Roche":[312],"Based":[316],"experience,":[319],"flexible":[323],"can":[325],"tailored":[327],"research":[334],"questions.":[335],"Trial":[336],"simulation":[337],"analyses":[338],"critical":[340],"us":[342],"understand":[344],"performance":[346],"accuracy":[352],"estimated":[354],"MTD,":[355],"trial":[356],"duration/sample":[357],"size,":[358],"sensitivity":[360],"assumptions.":[363],"Furthermore,":[364],"introduction":[366],"required":[372],"promoted":[374],"strong":[375],"multidisciplinary":[376],"collaborations,":[377],"especially":[378],"during":[379],"design":[381],"study":[383],"protocol":[384],"set-up":[385],"phases":[386],"phase.":[391],"Citation":[392],"Format:":[393],"Jiawen":[394],"Zhu,":[395],"Ulrich":[396],"Beyer,":[397],"Somnath":[398],"Sarkar,":[399],"Gwen":[400],"Nichols,":[401],"William":[402],"Pao,":[403],"Daniel":[404],"Saban\u00e9s":[405],"Bov\u00e9.":[406],"Experiences":[407],"lessons":[409],"early-phase":[416],"[abstract].":[418],"In:":[419],"Proceedings":[420],"American":[423],"Association":[424],"Cancer":[426,439],"Research":[427],"Annual":[428],"Meeting":[429],"2017;":[430],"2017":[431],"Apr":[432],"1-5;":[433],"Washington,":[434],"DC.":[435],"Philadelphia":[436],"(PA):":[437],"AACR;":[438],"Res":[440],"2017;77(13":[441],"Suppl):Abstract":[442],"nr":[443],"3597.":[444],"doi:10.1158/1538-7445.AM2017-3597":[445]},"counts_by_year":[],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2017-08-08T00:00:00"}